gamma-glutamylcysteine has been researched along with Encephalopathy, Toxic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, A; Guo, Z; Huang, Y; Luo, L; Yang, G; Yin, Z | 1 |
| Bastos, ML; Branco, PS; Capela, JP; Carvalho, F; Costa, VM; Fernandes, E; Ferreira, LM; Ferreira, PS; Meisel, A; Nogueira, TB | 1 |
2 other study(ies) available for gamma-glutamylcysteine and Encephalopathy, Toxic
| Article | Year |
|---|---|
γ-glutamylcysteine suppresses cadmium-induced apoptosis in PC12 cells via regulating oxidative stress.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cadmium Chloride; Dipeptides; Mitogen-Activated Protein Kinases; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Oxidative Stress; PC12 Cells; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2022 |
Neurotoxicity of "ecstasy" and its metabolites in human dopaminergic differentiated SH-SY5Y cells.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetylcysteine; Buthionine Sulfoximine; Cell Death; Cell Differentiation; Cell Line, Tumor; Dipeptides; Dopaminergic Neurons; Enzyme Inhibitors; Free Radical Scavengers; Glutathione; Humans; N-Methyl-3,4-methylenedioxyamphetamine; Neurotoxicity Syndromes; Piperazines | 2013 |